# OnCo record crossbow-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/crossbow-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "crossbow-therapeutics" ;
  schema:name "Crossbow Therapeutics"@en ;
  schema:description "Crossbow Therapeutics makes antibody medicines that recognise fragments of proteins from inside cancer cells and pull the immune system's T cells onto them. Its first medicine is being tested in leukaemias and related blood cancers."@en ;
  schema:url <https://onco.cc/companies/crossbow-therapeutics/>, <https://www.crossbowtx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.crossbowtx.com/>, <https://www.crossbowtx.com/press-release-03-18-26>, <https://www.crossbowtx.com/press-release-7-11-23>, <https://clinicaltrials.gov/study/NCT06994676>, <https://clinicaltrials.gov/study/NCT07779798> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds-higher-risk/>, <https://onco.cc/cancers/cmml/>, <https://onco.cc/cancers/cml/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> .